|
|
Article: Taro Pharmaceutical Industries announces Israel Ministry of Health approvals of carbamazepine controlled release tablets; first government approvals of a Taro controlled release delivery system.
- Article from:
- Business Wire
- Article date:
- September 24, 1996
CopyrightCOPYRIGHT 1996 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Sept. 24, 1996--Taro Pharmaceutical Industries Ltd. (NASDAQ/NMS:TAROF) Tuesday announced that it has received notification from the Israel Ministry of Health approving its applications for carbamazepine controlled release tablets, in strengths of 200 mg and 400 mg, for sale in Israel.
Taro's carbamazepine controlled release tablets are bioequivalent to Tegretol/a CR, an anticonvulsant which is used in the treatment of epilepsy and is sold in Israel, throughout Europe, and many other parts of the world. The company will sell its carbamazepine controlled release tablets in Israel under the brand name Teril/b CR.
In addition to ...